Mesothelioma Clinical Trials Search Tool
Find and explore mesothelioma clinical trials with our easy-to-use search tool and get connected with doctors conducting them. Search by location, trial phase, and specific disease presentation to discover cutting-edge treatment opportunities that may fit your diagnosis.
FILTER BY:
Details
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Address: 49 NY-347, Port Jefferson Station, NY 11776, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: No
- Peritoneal: No
- Pericardial: No
- Tunica Vaginalis: No
- Therapy Targeted: No
Type: N/A
Condition: Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors, Solid Tumor, Pancreatic Adenocarcinoma, Advanced Solid Tumor
Description: This is a Phase 1/2, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid tumor malignancy with homozygous deletion of the MTAP gene.
Research Center: New York Cancer and Blood Specialists
Treatment Interventions: DRUG: MRTX1719
Clinical Trial Number: NCT05245500
Phase: Phase 1, Phase 2
Status: Recruiting
